Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Human Fresh Corneal Lenticule Implantation Criteria in Progressive Corneal Disease Using Relex-Smile

NCT: NCT04848740 · ENROLLING_BY_INVITATION

NCT IDNCT04848740
StatusENROLLING_BY_INVITATION
Start Date2018-02-01
Completion2027-02-01
SponsorEye Hospital Pristina Kosovo (OTHER)
First posted
Last updated

Brief Summary

Stroma is a fibrous, tough, transparent and the thickest layer of the corneae. The stroma is composed of organised collagen, which maintains transparency. Keratocytes are located between the lamella collagen fibers and secrete an extracellular matrix, which includes collagen, proteoglycan, crystalline proteins to maintain corneal transparency.

Frequently Asked Questions

What is Human Fresh Corneal Lenticule Implantation Criteria in Progressive Corneal Disease Using Relex-Smile?

Human Fresh Corneal Lenticule Implantation Criteria in Progressive Corneal Disease Using Relex-Smile is a clinical trial registered under NCT04848740. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT04848740?

The current status of NCT04848740 (Human Fresh Corneal Lenticule Implantation Criteria in Progressive Corneal Disease Using Relex-Smile) is: ENROLLING_BY_INVITATION.

When did Human Fresh Corneal Lenticule Implantation Criteria in Progressive Corneal Disease Using Relex-Smile start?

Human Fresh Corneal Lenticule Implantation Criteria in Progressive Corneal Disease Using Relex-Smile started on 2018-02-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑